Endometrial endometrioid adenocarcinoma

Histology, precursors and molecular alterations

Helena Hwang, Kara Duncan, Paulette Mhawech-Fauceglia

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

Endometrioid adenocarcinoma is the most common endometrial cancer. It is highly associated with excess estrogen, whether endogenous or exogenous, and tends to be more common in post-menopausal women. Hyperplasia, with and without atypia, is considered a non-obligate precursor. In this review, we summarize the histologic features of endometrial hyperplasia and progestin therapy and review different classification systems for endometrioid adenocarcinoma precursors, including endometrial intraepithelial neoplasia. The histology, variants, and staging of endometrioid adenocarcinoma are also reviewed, with an emphasis on problematic areas in diagnosis, including assessment of myometrial and cervical stromal invasion, atypical hyperplasia versus adenocarcinoma, endometrial versus cervical primary, and endometrial versus ovarian primary versus synchronous primaries, and the application of immunohistochemical stains in diagnosis. In addition, pitfalls in diagnosis are discussed, such as endometrioid versus serous carcinoma and lymph node metastasis versus benign glandular inclusions. Lastly, molecular changes in endometrioid adenocarcinoma are explored.

Original languageEnglish (US)
Title of host publicationEndometrial Cancer: Current Epidemiology, Detection and Management
PublisherNova Science Publishers, Inc.
Pages65-85
Number of pages21
ISBN (Print)9781634631945, 9781634631631
StatePublished - Oct 1 2014

Fingerprint

Endometrioid Carcinoma
Histology
Hyperplasia
Endometrial Hyperplasia
Progestins
Endometrial Neoplasms
Estrogens
Adenocarcinoma
Coloring Agents
Lymph Nodes
Neoplasm Metastasis
Carcinoma
Neoplasms

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Hwang, H., Duncan, K., & Mhawech-Fauceglia, P. (2014). Endometrial endometrioid adenocarcinoma: Histology, precursors and molecular alterations. In Endometrial Cancer: Current Epidemiology, Detection and Management (pp. 65-85). Nova Science Publishers, Inc..

Endometrial endometrioid adenocarcinoma : Histology, precursors and molecular alterations. / Hwang, Helena; Duncan, Kara; Mhawech-Fauceglia, Paulette.

Endometrial Cancer: Current Epidemiology, Detection and Management. Nova Science Publishers, Inc., 2014. p. 65-85.

Research output: Chapter in Book/Report/Conference proceedingChapter

Hwang, H, Duncan, K & Mhawech-Fauceglia, P 2014, Endometrial endometrioid adenocarcinoma: Histology, precursors and molecular alterations. in Endometrial Cancer: Current Epidemiology, Detection and Management. Nova Science Publishers, Inc., pp. 65-85.
Hwang H, Duncan K, Mhawech-Fauceglia P. Endometrial endometrioid adenocarcinoma: Histology, precursors and molecular alterations. In Endometrial Cancer: Current Epidemiology, Detection and Management. Nova Science Publishers, Inc. 2014. p. 65-85
Hwang, Helena ; Duncan, Kara ; Mhawech-Fauceglia, Paulette. / Endometrial endometrioid adenocarcinoma : Histology, precursors and molecular alterations. Endometrial Cancer: Current Epidemiology, Detection and Management. Nova Science Publishers, Inc., 2014. pp. 65-85
@inbook{8fc69d83760f468fbbaeaeb2b40b2070,
title = "Endometrial endometrioid adenocarcinoma: Histology, precursors and molecular alterations",
abstract = "Endometrioid adenocarcinoma is the most common endometrial cancer. It is highly associated with excess estrogen, whether endogenous or exogenous, and tends to be more common in post-menopausal women. Hyperplasia, with and without atypia, is considered a non-obligate precursor. In this review, we summarize the histologic features of endometrial hyperplasia and progestin therapy and review different classification systems for endometrioid adenocarcinoma precursors, including endometrial intraepithelial neoplasia. The histology, variants, and staging of endometrioid adenocarcinoma are also reviewed, with an emphasis on problematic areas in diagnosis, including assessment of myometrial and cervical stromal invasion, atypical hyperplasia versus adenocarcinoma, endometrial versus cervical primary, and endometrial versus ovarian primary versus synchronous primaries, and the application of immunohistochemical stains in diagnosis. In addition, pitfalls in diagnosis are discussed, such as endometrioid versus serous carcinoma and lymph node metastasis versus benign glandular inclusions. Lastly, molecular changes in endometrioid adenocarcinoma are explored.",
author = "Helena Hwang and Kara Duncan and Paulette Mhawech-Fauceglia",
year = "2014",
month = "10",
day = "1",
language = "English (US)",
isbn = "9781634631945",
pages = "65--85",
booktitle = "Endometrial Cancer: Current Epidemiology, Detection and Management",
publisher = "Nova Science Publishers, Inc.",

}

TY - CHAP

T1 - Endometrial endometrioid adenocarcinoma

T2 - Histology, precursors and molecular alterations

AU - Hwang, Helena

AU - Duncan, Kara

AU - Mhawech-Fauceglia, Paulette

PY - 2014/10/1

Y1 - 2014/10/1

N2 - Endometrioid adenocarcinoma is the most common endometrial cancer. It is highly associated with excess estrogen, whether endogenous or exogenous, and tends to be more common in post-menopausal women. Hyperplasia, with and without atypia, is considered a non-obligate precursor. In this review, we summarize the histologic features of endometrial hyperplasia and progestin therapy and review different classification systems for endometrioid adenocarcinoma precursors, including endometrial intraepithelial neoplasia. The histology, variants, and staging of endometrioid adenocarcinoma are also reviewed, with an emphasis on problematic areas in diagnosis, including assessment of myometrial and cervical stromal invasion, atypical hyperplasia versus adenocarcinoma, endometrial versus cervical primary, and endometrial versus ovarian primary versus synchronous primaries, and the application of immunohistochemical stains in diagnosis. In addition, pitfalls in diagnosis are discussed, such as endometrioid versus serous carcinoma and lymph node metastasis versus benign glandular inclusions. Lastly, molecular changes in endometrioid adenocarcinoma are explored.

AB - Endometrioid adenocarcinoma is the most common endometrial cancer. It is highly associated with excess estrogen, whether endogenous or exogenous, and tends to be more common in post-menopausal women. Hyperplasia, with and without atypia, is considered a non-obligate precursor. In this review, we summarize the histologic features of endometrial hyperplasia and progestin therapy and review different classification systems for endometrioid adenocarcinoma precursors, including endometrial intraepithelial neoplasia. The histology, variants, and staging of endometrioid adenocarcinoma are also reviewed, with an emphasis on problematic areas in diagnosis, including assessment of myometrial and cervical stromal invasion, atypical hyperplasia versus adenocarcinoma, endometrial versus cervical primary, and endometrial versus ovarian primary versus synchronous primaries, and the application of immunohistochemical stains in diagnosis. In addition, pitfalls in diagnosis are discussed, such as endometrioid versus serous carcinoma and lymph node metastasis versus benign glandular inclusions. Lastly, molecular changes in endometrioid adenocarcinoma are explored.

UR - http://www.scopus.com/inward/record.url?scp=84957947122&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84957947122&partnerID=8YFLogxK

M3 - Chapter

SN - 9781634631945

SN - 9781634631631

SP - 65

EP - 85

BT - Endometrial Cancer: Current Epidemiology, Detection and Management

PB - Nova Science Publishers, Inc.

ER -